[Angioimmunoblastic T-cell lymphoma presenting with rapidly increasing biclonal gammopathy]

T Tasaka1, Y Matsuhashi, E Uehara

  • 1Department of Medicine, Kagawa Prefectural, Central Hospital.

Insights

This study reports a rare case of angioimmunoblastic T-cell lymphoma presenting with biclonal gammopathy. The findings highlight a complex interplay between lymphoma, immune dysregulation, and protein abnormalities.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Angioimmunoblastic T-cell lymphoma (AITL) is an aggressive non-Hodgkin lymphoma characterized by systemic symptoms and lymphadenopathy.
  • Gammopathy, particularly monoclonal gammopathy, can occur in AITL, but biclonal gammopathy is exceptionally rare.

Observation:

  • A 59-year-old male presented with fever, dysphagia, a lingual tumor, and enlarged cervical and inguinal lymph nodes.
  • Lymph node biopsy revealed effacement of normal architecture by atypical lymphocytes and prominent high endothelial venules.
  • Genetic analysis confirmed T-cell receptor beta gene rearrangement, supporting a T-cell origin.

Findings:

  • The patient was diagnosed with angioimmunoblastic T-cell lymphoma.
  • Serial protein analysis revealed rapidly increasing M-protein with immunofixation electrophoresis confirming biclonal gammopathy (IgG kappa and IgM lambda).
  • This represents a rare co-occurrence of biclonal gammopathy in AITL.

Implications:

  • The case underscores the importance of comprehensive protein analysis in AITL patients to detect rare complications like biclonal gammopathy.
  • Further research is warranted to elucidate the mechanisms linking AITL, biclonal gammopathy, and potential viral associations (HHV-6, HHV-8, EBV).
  • Understanding these associations may lead to improved diagnostic and therapeutic strategies for AITL.

Related Concept Videos